The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Medirax 2.5 mg nasal spray, solution in single-dose container

Medir B.V.PA22954/001/001

Main Information

Trade NameMedirax 2.5 mg nasal spray, solution in single-dose container
Active SubstancesMidazolam hydrochloride
Dosage FormNasal spray, solution in single-dose container
Licence HolderMedir B.V.
Licence NumberPA22954/001/001

Group Information

ATC CodeN05CD08 midazolam


License statusAuthorised
Licence Issued20/01/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back